Pharmaceuticals

FDA grants new marketing authorization to Labcorp’s genomic testing kit

bexib
By bexib 0 Min Read

PGDx elio PlasmaFocus Dx provides laboratories with a testing option even in situations where sample availability is difficult.

You Might Also Like

Surprising inefficiencies in field deployment

Metabolon Adds New Data to Platform to Improve Biomarker Discovery

FDA grants Priority Review to mirdametinib for neurofibromatosis type 1-associated plexiform neurofibromas

FDA approves Filspari for adult patients with IgA nephropathy

Pharma Pulse 6/3/24: Impact of serialization technology, strategies to help health plans prepare for risk adjustment, and more

Share This Article
Previous Article Growing conservative opposition to carbon capture and storage
Next Article MAS Grants HashKey OTC License for Cryptocurrency Payments
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Cambodian Bakong tourist app now supports Visa cards for payment
Fintech
Techcombank’s digital channels drive growth to 15 million users in 2024
Fintech
Top 10 largest fintech acquisitions in Southeast Asia
Fintech
Revolut launches robo-advisor in Singapore
Fintech